NCT07886801
A Study of Ropeg-Interferon in People With Polycythemia Vera
StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Recruitment opened
- Site details revised at 7 of 7 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Proportion of patients who meet criteria for treatment discontinuation
Timeframe: 24 months
Secondary (1)
Proportion of patients who meet criteria for treatment discontinuation
Arms and interventions
Ropeg-Interferon in People With Polycythemia VeraExperimental
Each patient will receive ropeg-IFN subcutaneously.
Drugs: Ropeginterferon
Sites
7 sites in 1 country